SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051288
Filing Date
2020-11-05
Accepted
2020-11-05 16:03:07
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20200930.htm   iXBRL 10-Q 2687356
2 LOAN AND SECURITY AGREEMENT gern-ex101_29.htm EX-10.1 608368
3 EX-31.1 gern-ex311_7.htm EX-31.1 17407
4 EX-31.2 gern-ex312_6.htm EX-31.2 17421
5 EX-32.1 gern-ex321_8.htm EX-32.1 7639
6 EX-32.2 gern-ex322_9.htm EX-32.2 7621
  Complete submission text file 0001564590-20-051288.txt   9238935

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gern-20200930.xsd EX-101.SCH 40761
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20200930_cal.xml EX-101.CAL 53639
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20200930_def.xml EX-101.DEF 136111
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20200930_lab.xml EX-101.LAB 354932
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20200930_pre.xml EX-101.PRE 250311
12 EXTRACTED XBRL INSTANCE DOCUMENT gern-10q_20200930_htm.xml XML 1760309
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 201290356
SIC: 2834 Pharmaceutical Preparations